🇪🇺 Angiomax in European Union

Angiomax (BIVALIRUDIN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000562
  • Local brand name: Angiox
  • Status: withdrawn

Angiomax in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in European Union

Frequently asked questions

Is Angiomax approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Angiomax in European Union?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.